News & Stories
The WHO recently approved new, safe TB treatments from the PIH-led endTB trial, offering hope for patients with MDR-TB and RR-TB. These treatments, backed by years of research, promise better outcomes for many.
Paul Soko, PIH Lesotho’s infrastructure coordinator, transformed Botšabelo Hospital over 14 years, designing and building essential facilities. Now retiring, he aims to improve lives through his family’s farming business.
PIH Lesotho plays a critical role in combating TB, providing not only medical care but also social support to patients. Awareness, early diagnosis, and adherence to treatment are crucial. Sarafina’s journey is a reminder of the importance of these elements and the incredible strength it takes to endure such a battle.
PIH Lesotho equipped all Rural Health Initiative (RI) sites with solar infrastructure, significantly enhancing healthcare delivery.
In 2022, Qabane was diagnosed with multidrug-resistant tuberculosis (MDR-TB) at Partners In Health (PIH)-supported Nkau Health Center and immediately began treatment, which includes medication and social support, such as food and transportation.
Through the OVC program, Mankopane and her brother received mental health support, including therapy sessions. Other support included school fees and supplies, food, clothes, and medical care.
Mahapa, who grew up in rural Lesotho, was diagnosed with HIV in 2019. Two years later, he contracted tuberculosis.
Nthabiseng Mokone, a 27-year-old patient with multidrug-resistant tuberculosis (MDR-TB). After spending six months in inpatient care, Mokone recently reunited with her loved ones.